Effects of antibiotics on RNA polymerase III transcription.
We investigated the effects of six drugs on an RNA polymerase III in vitro transcription system. Adriamycin, daunorubicin, heparin, rifamycin AF/013, streptolydigin, and streptovaricin all inhibit RNA synthesis from a tRNA gene or the adenovirus 2 (AD2) VA1 RNA gene. The completed RNA polymerase III transcription complex is formed by the sequential, ordered addition of protein factors. Although both genes reportedly use the same transcription fractions for in vitro RNA synthesis, some of these drugs interfere differentially with these genes. A drug concentration that inhibits transcription from one gene may not inhibit transcription from the other gene. Adriamycin seems to block transcription if added between the binding of the individual transcription fractions. Daunorubicin appears to inhibit VA transcription only if added prior to both transcription fractions, but inhibits tRNA synthesis before and during transcription factor binding. Heparin blocks both genes between factors binding to DNA and after factor binding. Rifamycin blocks VA synthesis more effectively than tRNA synthesis. Streptolydigin blocks transcription of both genes. Streptovaricin probably blocks transcription by inhibiting early transcription complex assembly events. These drugs appear useful as appropriate probes to investigate transcription complexes since several discriminate between complexes formed on different genes during the assembly process.
Logan
K
K
Biology Department, University of Massachusetts, Boston 02125.
Ackerman
S
S
D000260:Adenoviruses, Human / Q000235:genetics; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003600:Cytosol / Q000201:enzymology; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors*; D003630:Daunorubicin / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D005796:Genes / Q000187:drug effects; D005814:Genes, Viral / Q000187:drug effects; D006367:HeLa Cells / Q000201:enzymology; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D012320:RNA Polymerase III / Q000037:antagonists & inhibitors*; D012294:Rifamycins / Q000494:pharmacology; D013310:Streptovaricin / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D012294:Rifamycins; D013310:Streptovaricin; C006019:AF 013; C100307:streptolydigin; D004317:Doxorubicin; D006493:Heparin; D012321:DNA-Directed RNA Polymerases; D012320:RNA Polymerase III; D003630:Daunorubicin